Conmed (CNMD) FCF Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Conmed | 1.06 Bn | 1.02 Bn | 183.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -493.00 |
| Dec 31, 2025 | 432.00 |
| Sep 30, 2025 | 96.00 |
| Jun 30, 2025 | 570.00 |
| Mar 31, 2025 | 1,133.00 |
| Dec 31, 2024 | -174.00 |
| Sep 30, 2024 | 150.00 |
| Jun 30, 2024 | 500.00 |
| Mar 31, 2024 | 1,231.00 |
| Dec 31, 2023 | 753.00 |
| Sep 30, 2023 | 1,343.00 |
| Jun 30, 2023 | -107.00 |
| Mar 31, 2023 | -1,325.00 |
| Dec 31, 2022 | -1,462.00 |
| Sep 30, 2022 | 186.00 |
| Jun 30, 2022 | -194.00 |
| Mar 31, 2022 | -820.00 |
| Dec 31, 2021 | 657.00 |
| Sep 30, 2021 | -556.00 |
| Jun 30, 2021 | 549.00 |
| Mar 31, 2021 | 1,894.00 |
| Dec 31, 2020 | 219.00 |
| Sep 30, 2020 | 749.00 |
| Jun 30, 2020 | -247.00 |
| Mar 31, 2020 | -562.00 |
| Dec 31, 2019 | 156.00 |
| Sep 30, 2019 | 729.00 |
| Jun 30, 2019 | 520.00 |
| Mar 31, 2019 | -1,076.00 |
| Dec 31, 2018 | -279.00 |
| Sep 30, 2018 | -1,407.00 |
| Jun 30, 2018 | 99.00 |
| Mar 31, 2018 | 979.00 |
| Dec 31, 2017 | -637.00 |
| Sep 30, 2017 | -787.00 |
| Jun 30, 2017 | -416.00 |
| Mar 31, 2017 | 619.00 |
| Dec 31, 2016 | -694.00 |
| Sep 30, 2016 | -684.00 |
| Jun 30, 2016 | -146.00 |
| Mar 31, 2016 | -1,970.00 |
| Dec 31, 2015 | -583.00 |
| Sep 30, 2015 | 1,068.00 |